Skip to main content

Advertisement

Log in

Pokemon promotes the invasiveness of hepatocellular carcinoma by enhancing MEF2D transcription

  • Original Article
  • Published:
Hepatology International Aims and scope Submit manuscript

Abstract

Background

Pokemon, a master oncogene crucial for the tumorigenicity and progression of a variety of cancers, has been demonstrated to enhance the proliferation and survival of hepatocellular carcinoma (HCC). However, the contribution of Pokemon to the invasiveness of HCC has not yet been studied.

Methods

In this study, we employed HCC cells to investigate the role of Pokemon in the invasion of HCC with multidisciplinary approaches.

Results

Pokemon overexpression was found to be closely associated with invasion and intrahepatic metastasis of HCC in clinical specimens. Suppression of Pokemon attenuated the invasion of HCC cells by in vitro transwell and wound-healing assays. Myocyte enhancer factor 2D (MEF2D), an oncogene that can promote the invasiveness of HCC, was found to be underexpressed during Pokemon silencing in HCC cells. Restoration of MEF2D abolished the effect of Pokemon downregulation on the migration of HCC cells. Further experiments verified that Pokemon binds two putative recognition sites located within the upstream region of the MEF2D promoter and enhances its transcription. The association between Pokemon and MEF2D was further confirmed in HCC specimens. Animal experiments further confirmed that Pokemon downregulation attenuated the metastasis of HCC cells in mice.

Conclusion

Collectively, Pokemon was found to enhance the migration and invasion of HCC by increasing MEF2D expression. Thus, targeting Pokemon and MEF2D may be an effective strategy to suppress the metastasis of HCC.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8
Fig. 9

Similar content being viewed by others

References

  1. Maeda T, Hobbs RM, Merghoub T, Guernah I, Zelent A, Cordon-Cardo C, et al. Role of the proto-oncogene Pokemon in cellular transformation and ARF repression. Nature 2005;433:278–285

    Article  CAS  PubMed  Google Scholar 

  2. He S, Liu F, Xie Z, Zu X, Xu W, Jiang Y. P-Glycoprotein/MDR1 regulates pokemon gene transcription through p53 expression in human breast cancer cells. Int J Mol Sci 2010;11:3039–3051

    Article  CAS  Google Scholar 

  3. Lin CC, Zhou JP, Liu YP, Liu JJ, Yang XN, Jazag A, et al . The silencing of Pokemon attenuates the proliferation of hepatocellular carcinoma cells in vitro and in vivo by inhibiting the PI3 K/Akt pathway. PLoS ONE 2012;7:e51916

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Zhang QL, Tian DA, Xu XJ. Depletion of Pokemon gene inhibits hepatocellular carcinoma cell growth through inhibition of H-ras. Onkologie 2011;34:526–531

    Article  CAS  PubMed  Google Scholar 

  5. Zhang YQ, Xiao CX, Lin BY, Shi Y, Liu YP, Liu JJ, et al. Silencing of Pokemon enhances caspase-dependent apoptosis via fas- and mitochondria-mediated pathways in hepatocellular carcinoma cells. PLoS ONE 2013;8:e68981

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Liu K, Liu F, Zhang N, Liu S, Jiang Y. Pokemon Silencing Leads to Bim-Mediated Anoikis of Human Hepatoma Cell QGY7703. Int J Mol Sci 2012;13:5818–5831

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Zhang NN, Sun QS, Chen Z, Liu F, Jiang YY. Homeostatic regulatory role of Pokemon in NF-kappaB signaling: stimulating both p65 and IkappaBalpha expression in human hepatocellular carcinoma cells. Mol Cell Biochem 2013;372:57–64

    Article  CAS  PubMed  Google Scholar 

  8. Jin XL, Sun QS, Liu F, Yang HW, Liu M, Liu HX, et al. microRNA 21-mediated suppression of Sprouty1 by Pokemon affects liver cancer cell growth and proliferation. J Cell Biochem 2013;114:1625–1633

    Article  CAS  PubMed  Google Scholar 

  9. Ding Y, Wang W, Feng M, Wang Y, Zhou J, Ding X, et al. A biomimetic nanovector-mediated targeted cholesterol-conjugated siRNA delivery for tumor gene therapy. Biomaterials 2012;33:8893–8905

    Article  CAS  PubMed  Google Scholar 

  10. Potthoff MJ, Olson EN. MEF2: a central regulator of diverse developmental programs. Development 2007;134:4131–4140

    Article  CAS  PubMed  Google Scholar 

  11. Ma L, Liu J, Liu L, Duan G, Wang Q, Xu Y, et al. Overexpression of the transcription factor MEF2D in hepatocellular carcinoma sustains malignant character by suppressing G2-M transition genes. Cancer Res 2014;74:1452–1462

    Article  CAS  PubMed  Google Scholar 

  12. Yu W, Huang C, Wang Q, Huang T, Ding Y, Ma C, et al. MEF2 transcription factors promotes EMT and invasiveness of hepatocellular carcinoma through TGF-beta1 autoregulation circuitry. Tumour Biol 2014;35:10943–10951

    Article  CAS  PubMed  Google Scholar 

  13. Li W, Kidiyoor A, Hu Y, Guo C, Liu M, Yao X, et al. Evaluation of transforming growth factor-beta1 suppress Pokemon/epithelial-mesenchymal transition expression in human bladder cancer cells. Tumour Biol 2015;36:1155–1162

    Article  CAS  PubMed  Google Scholar 

  14. Yang X, Zu X, Tang J, Xiong W, Zhang Y, Liu F, et al. Zbtb7 suppresses the expression of CDK2 and E2F4 in liver cancer cells: implications for the role of Zbtb7 in cell cycle regulation. Mol Med Rep 2012;5:1475–1480

    CAS  PubMed  Google Scholar 

  15. Zu X, Ma J, Liu H, Liu F, Tan C, Yu L, et al. Pro-oncogene Pokemon promotes breast cancer progression by upregulating survivin expression. Breast Cancer Res 2011;13:R26

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Funding

This study was funded by the Jiangsu Provincial Special Program of Medical Science (BL2013021) and the Huai’an Science foundation (SN12037).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jing Kong.

Ethics declarations

Conflict of interest

Jing Kong, Xiaoping Liu, Xiangqian Li, Jinsheng Wu, Ning Wu, Jun Chen, and Fang Fang declare that they have no conflict of interest.

Ethical standards

All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (Huai’an First People’s Hospital, China) and with the Helsinki Declaration of 1975, as revised in 2008. Informed consent was obtained from all patients for being included in the study. Fresh HCC samples were collected from patients with their written informed consent at the Department of Hepatopancreatobiliary Surgery, Huai’an First People’s Hospital (Huai’an, China). This study had been approved by the Ethical Review Board in the Review Board of Huai’an First People’s Hospital (No. 201403, Huai’an, China).

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (DOCX 44 kb)

Supplementary material 2 (PPTX 148 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kong, J., Liu, X., Li, X. et al. Pokemon promotes the invasiveness of hepatocellular carcinoma by enhancing MEF2D transcription. Hepatol Int 10, 493–500 (2016). https://doi.org/10.1007/s12072-015-9697-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12072-015-9697-y

Keywords

Navigation